Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 2.5601
-1.91 %
$ 3.43 M
Market Cap
-2.59
P/E
INCOME STATEMENT
12.7 M
REVENUE
-4.7 M
OPERATING INCOME
-4.84 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Sonoma Pharmaceuticals, Inc.
| Revenue | 12.7 M |
| Cost Of Revenue | 7.99 M |
| Gross Profit | 4.74 M |
| Operating Expenses | 9.45 M |
| Operating Income | -4.7 M |
| Other Expenses | 134 K |
| Net Income | -4.84 M |
Income Statement
Millions
| Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 | Mar-2010 | Mar-2009 | Mar-2008 | Mar-2007 | Mar-2006 | Mar-2005 | Mar-2004 | Mar-2003 | Mar-2002 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||||||||||||
| Revenue | 12.7 | 13.3 | 12.6 | 18.6 | 18.9 | 19.0 | 16.7 | 12.8 | 15.1 | 13.9 | 13.7 | 15.5 | 12.7 | 9.8 | 7.4 | 5.4 | 3.8 | 4.5 | 2.6 | 1.4 | 0.9 | 2.5 | 2.0 |
| GROSS PROFIT | |||||||||||||||||||||||
| Cost Of Revenue | 8.0 | 8.8 | 8.6 | 12.1 | 10.6 | 10.1 | 9.3 | 7.2 | 7.9 | 6.6 | 5.3 | 4.7 | 4.0 | 3.6 | 3.5 | 2.6 | 2.8 | 3.0 | 4.9 | 3.5 | 0 | 1.8 | 0.8 |
| Gross Profit | 4.7 | 4.5 | 4.0 | 6.6 | 8.3 | 8.9 | 7.3 | 5.7 | 7.2 | 7.3 | 8.4 | 10.7 | 8.7 | 6.1 | 3.9 | 2.8 | 1.1 | 1.5 | (2.3) | (2.2) | 0.9 | 0.7 | 1.2 |
| OPERATING INCOME | |||||||||||||||||||||||
| Operating Expenses | 9.4 | 9.0 | 9.9 | 10.0 | 15.0 | 20.1 | 21.5 | 18.6 | 17.4 | 13.9 | 14.4 | 14.1 | 15.2 | 13.6 | 11.9 | 20.1 | 23.5 | 21.0 | 18.5 | 14.1 | 0 | 2.2 | 1.3 |
| Selling, General and Administrative Expenses | 7.6 | 8.8 | 9.8 | 9.5 | 13.7 | 18.6 | 19.9 | 17.1 | 15.6 | 12.4 | 11.6 | 11.9 | 13.2 | 11.6 | 9.9 | 13.9 | 13.7 | 16.5 | 15.9 | 12.5 | 0 | 2.1 | 1.3 |
| Research and Development Expenses | 1.9 | 0.2 | 0.1 | 0.6 | 1.3 | 1.5 | 1.6 | 1.6 | 1.8 | 1.5 | 2.9 | 2.2 | 2.0 | 2.0 | 2.0 | 6.3 | 9.8 | 4.5 | 2.6 | 1.7 | 0 | 68 K | 6 K |
| Operating Income | (4.7) | (4.6) | (5.9) | (3.4) | (6.7) | (11.3) | (14.2) | (13.0) | (10.2) | (6.7) | (6.1) | (3.4) | (6.5) | (7.5) | (8.0) | (17.3) | (22.4) | (19.5) | (20.9) | (16.3) | 0.9 | (1.5) | (0.1) |
| PRE-TAX INCOME | |||||||||||||||||||||||
| Interest Income Expense | 0 | 16 K | 10 K | 12 K | 16 K | 33 K | 40 K | 3 K | 3 K | 3 K | 1.1 | 1.1 | 0.9 | 0.4 | 9 K | 0.4 | (1.0) | (1.0) | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | (0.3) | (0.6) | 0.5 | (0.5) | 3.8 | 82 K | (0.1) | 37 K | 10 K | (1.5) | 9.8 | (2.1) | (0.9) | (0.4) | (0.2) | (0.3) | 2.1 | (0.3) | (0.3) | (0.2) | (0.9) | 4 K | 4 K |
| Pre-Tax Income | (5.0) | (5.2) | (5.4) | (3.9) | (2.8) | (11.3) | (14.3) | (12.9) | (10.2) | (8.2) | 3.7 | (5.4) | (7.3) | (7.9) | (8.2) | (17.7) | (20.3) | (19.8) | (21.2) | (16.2) | 0 | (1.5) | (0.1) |
| NET INCOME | |||||||||||||||||||||||
| Tax Provision | (0.2) | 33 K | (0.3) | 0.7 | 0.1 | 0.5 | (0.8) | (4.3) | (0.2) | (0.2) | 0.8 | 0.8 | 0.9 | 0.4 | (0.2) | 0.3 | (2.1) | 0.3 | 2.2 | 0.2 | 8.0 | 0.1 | 24 K |
| Net Income | (4.8) | (5.2) | (5.1) | (4.6) | (2.9) | (11.8) | (14.3) | 9.3 | (10.2) | (8.2) | 3.7 | (5.4) | (7.3) | (7.9) | (8.2) | (17.7) | (20.3) | (19.8) | (23.1) | (16.5) | (7.3) | (1.6) | (0.2) |
| EPS | 10.6 | 30.4 | 38.4 | 46.2 | 39.8 | 255 | 570 | 391 | 556 | 764 | 486 | 982 | 1.69 K | 1.9 K | 2.26 K | 6.86 K | 10.1 K | 22.9 K | 35.1 K | 26.6 K | 11.8 K | 2.63 K | 277 |